Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

304360.KQ

STRONG SELL

S.Biomedics Co., Ltd. · Healthcare · South Korea · $225M · Avg Vol: $2M/d

9
StockRank
Q
27
V
35
M
30
P/E (TTM)
—
ROE
-41.2%
D/E
0.8x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue8M9M9M11M11.0%
EPS-0.41-0.62-0.38-0.45—
Shares10M11M12M12M+16.9%
Debt9M8M12M8M-4.0%
Equity-2M5M8M6M11.2%
Op CF-2M-4M-2M-3M—
Inv CF-5M-6M-7M4M—
Fin CF5M8M11M114,135—
Loading...
PRICE (1M)-30.1%
15.7017.3919.0720.7622.45May 6May 28Jun 18
SMA 50SMA 200
Close
$15.70
RSI (14)
35.2
52W High
$28.04
From 52W High
0.6%

SCORE BREAKDOWN

Quality
27
ROIC
-18.5%29.1
ROE
-41.2%20.4
GP/Assets
18.7%43.7
Op. Margin
-68.0%19.0
FCF/Assets
-24.8%12.6
Piotroski
—28.7
Int. Cover
-3.7x31.6
D/E Ratio
0.79x19.5
Current Ratio
1.87x34.5
Value
35
P/E (TTM)
—N/A
EV/EBITDA
-52.8x94.1
P/FCF
—N/A
P/B
40.1x2.1
P/S
20.8x16.8
Div Yield
—N/A
Momentum
30
52W High %
56%32.8
RS 6M
-142%4.5
SMA 50/200
1.04x70.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$225M
P/E (Forward)
—
Gross Margin
46.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 304360.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
304360.KQS.Biomedics Co., Ltd.(you)$225M9STRONG SELL
228760.KQGenomictree Inc.$216M9STRONG SELL
389650.KQNEXTBIOMEDICAL$217M12STRONG SELL
199800.KQToolGen Incorporated$266M11STRONG SELL
215600.KQSillaJen, Inc.$233M13STRONG SELL
287840.KQIntoCell, Inc.$227M2STRONG SELL
376270.KQHEM Pharma Inc.$203M3STRONG SELL
308430.KQCellbion$150M8STRONG SELL
493280.KQIMBiologics$259M2STRONG SELL
424870.KQImmuneOncia$252M1STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.4%

S.Biomedics Co., Ltd. (304360.KQ) — Stock Score Summary

S.Biomedics Co., Ltd. (304360.KQ) has a MoatMap StockRank of 9/100 based on Quality (27/100), Value (35/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL.

S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.

Key Financial Metrics

Price$15.70
Market Cap$225M
Price/Book40.06
Return on Equity-41.2%
Return on Invested Capital-18.5%
Debt/Equity78.67
Gross Margin46.7%
Operating Margin-68.0%
Revenue Growth-1.4%
Free Cash Flow$-4K

S.Biomedics Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is S.Biomedics Co., Ltd.’s (304360.KQ) StockRank?
MoatMap’s StockRank for S.Biomedics Co., Ltd. (304360.KQ) is 9/100, with a Strong Sell signal. It is a composite of Quality (27), Value (35), and Momentum (30) factor ranks across MoatMap’s 20,000+ stock universe.
Does S.Biomedics Co., Ltd. have an economic moat?
S.Biomedics Co., Ltd. (304360.KQ) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is S.Biomedics Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for S.Biomedics Co., Ltd. (304360.KQ) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is S.Biomedics Co., Ltd. in?
S.Biomedics Co., Ltd. (304360.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks304360.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock